Madu MF - Search Results

1

Clinical Prognostic Markers in Stage IIIB Melanoma.

Madu MF, Wouters MW, Klop WM, van der Hiel B, van de Wiel BA, Jóźwiak K, van der Hage JA, van Akkooi AC. Madu MF, et al. Ann Surg Oncol. 2016 Dec;23(13):4195-4202. doi: 10.1245/s10434-016-5396-8. Epub 2016 Jul 5. Ann Surg Oncol. 2016. PMID: 27380642

2

Sentinel node biopsy in melanoma: Current controversies addressed.

Madu MF, Wouters MW, van Akkooi AC. Madu MF, et al. Eur J Surg Oncol. 2017 Mar;43(3):517-533. doi: 10.1016/j.ejso.2016.08.007. Epub 2016 Aug 24. Eur J Surg Oncol. 2017. PMID: 27590685 Review.

3

Comment: Detailed Pathologic Examination of Completion Node Dissection Specimens and Outcome for Melanoma Patients with Minimal (< 0.1 mm) Sentinel Lymph Node Metastases.

Madu MF, van de Wiel B, van Akkooi ACJ. Madu MF, et al. Ann Surg Oncol. 2017 Dec;24(Suppl 3):658-659. doi: 10.1245/s10434-017-6169-8. Epub 2017 Nov 7. Ann Surg Oncol. 2017. PMID: 29116486 No abstract available.

4

Blue dye can be safely omitted in most sentinel node procedures for melanoma.

van der Ploeg IM, Madu MF, van der Hage JA, Wouters MW, Klop WM, van der Hiel B, van de Wiel BA, van Akkooi AJ. van der Ploeg IM, et al. Among authors: madu mf. Melanoma Res. 2016 Oct;26(5):464-8. doi: 10.1097/CMR.0000000000000271. Melanoma Res. 2016. PMID: 27232099

5

Isolated Limb Perfusion for Melanoma is Safe and Effective in Elderly Patients.

Madu MF, Deken MM, van der Hage JA, Jóźwiak K, Wouters MWJM, van Akkooi ACJ. Madu MF, et al. Ann Surg Oncol. 2017 Jul;24(7):1997-2005. doi: 10.1245/s10434-017-5803-9. Epub 2017 Feb 10. Ann Surg Oncol. 2017. PMID: 28188500

6

PET/CT surveillance detects asymptomatic recurrences in stage IIIB and IIIC melanoma patients: a prospective cohort study.

Madu MF, Timmerman P, Wouters MWJM, van der Hiel B, van der Hage JA, van Akkooi ACJ. Madu MF, et al. Melanoma Res. 2017 Jun;27(3):251-257. doi: 10.1097/CMR.0000000000000347. Melanoma Res. 2017. PMID: 28225434

7

Clinical prognostic markers in stage IIIC melanoma.

Madu MF, Schopman JHH, Berger DMS, Klop WMC, Jóźwiak K, Wouters MWJM, van der Hage JA, van Akkooi ACJ. Madu MF, et al. J Surg Oncol. 2017 Aug;116(2):244-251. doi: 10.1002/jso.24635. Epub 2017 Apr 15. J Surg Oncol. 2017. PMID: 28411392

8

Challenges in sentinel node pathology in the era of adjuvant treatment.

Franke V, Madu MF, Bierman C, Klop WMC, van Houdt WJ, Wouters MWJM, van de Wiel BA, van Akkooi ACJ. Franke V, et al. Among authors: madu mf. J Surg Oncol. 2020 Oct;122(5):964-972. doi: 10.1002/jso.26095. Epub 2020 Jun 29. J Surg Oncol. 2020. PMID: 32602119

9

Immediate completion lymph node dissection in stage IIIA melanoma does not provide significant additional staging information beyond EORTC SN tumour burden criteria.

Madu MF, Franke V, Bruin MM, Berger DMS, Bierman C, Jóźwiak K, Klop WMC, Wouters MWJM, van Akkooi ACJ, Van de Wiel BA. Madu MF, et al. Eur J Cancer. 2017 Dec;87:212-215. doi: 10.1016/j.ejca.2017.09.002. Epub 2017 Oct 3. Eur J Cancer. 2017. PMID: 28986137 No abstract available.

10

External validation of the American Joint Committee on Cancer 8th edition melanoma staging system: who needs adjuvant treatment?

Madu MF, Franke V, Van de Wiel BA, Klop WMC, Jóźwiak K, van Houdt WJ, Wouters MWJM, van Akkooi ACJ. Madu MF, et al. Melanoma Res. 2020 Apr;30(2):185-192. doi: 10.1097/CMR.0000000000000643. Melanoma Res. 2020. PMID: 31651715

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

19 results

Search Page